Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacologyKahina Hammam(Centre National de la Recherche Scientifique), Patrice Dubreuil(Centre National de la Recherche Scientifique)Nature CommunicationsNovember 6, 201710.1038/s41467-017-01582-5Cited by 24SaveCiteExport RISWatch citationsRelated PapersMasitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT|PLoS ONE|2009|409Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model|PLoS ONE|2010|75